Proteomic profiling using mass spectrometry – does normalising by total ion current potentially mask some biological differences?

Normalisation of data to minimise the impact of technical variation on comparative sample analysis is often carried out. Using SELDI data as a model, we have examined the effects of normalisation by TIC which is commonly used for MS data. Significant intergroup differences in normalisation factor were found for serum profiles which could not be explained by experimental factors, implying that normalisation by TIC may in some situations also normalise biological differences and should be systematically evaluated.

[1]  J. Sung,et al.  Technical evaluation of MALDI-TOF mass spectrometry for quantitative proteomic profiling matrix formulation and application , 2004, Clinical Proteomics.

[2]  Ian Eardley,et al.  Urinary biomarker profiling in transitional cell carcinoma , 2006, International journal of cancer.

[3]  Martin Vingron,et al.  Normalization and quantification of differential expression in gene expression microarrays , 2006, Briefings Bioinform..

[4]  W. Wodzig,et al.  Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[5]  Annette Kopp-Schneider,et al.  Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra. , 2006, Journal of proteome research.

[6]  Stephen J. Callister,et al.  Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. , 2006, Journal of proteome research.

[7]  Jeffrey S. Morris,et al.  Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform , 2005, Proteomics.

[8]  P. Wentzell,et al.  DNA microarrays: is there a role for analytical chemistry? , 2005, The Analyst.

[9]  J. Barrett,et al.  Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. , 2005, Clinical chemistry.

[10]  R. Higgs,et al.  Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2005, BioTechniques.

[11]  Jeffrey S. Morris,et al.  Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum , 2005, Bioinform..

[12]  J. Listgarten,et al.  Statistical and Computational Methods for Comparative Proteomic Profiling Using Liquid Chromatography-Tandem Mass Spectrometry , 2005, Molecular & Cellular Proteomics.

[13]  Rosamonde E Banks,et al.  Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies , 2005, Proteomics.

[14]  D. Chan,et al.  Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. , 2005, Clinical chemistry.

[15]  Arlan Richardson,et al.  Processing of data generated by 2-dimensional gel electrophoresis for statistical analysis: missing data, normalization, and statistics. , 2004, Journal of proteome research.

[16]  Kathryn S. Lilley,et al.  DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results , 2004, Bioinform..

[17]  P. Selby,et al.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.

[18]  A. Pothen,et al.  Protocols for disease classification from mass spectrometry data , 2003, Proteomics.

[19]  Martin R. Johnson,et al.  Housekeeping gene variability in normal and carcinomatous colorectal and liver tissues: applications in pharmacogenomic gene expression studies. , 2002, Analytical biochemistry.

[20]  A. Shaw,et al.  Protein creatinine index and Albustix in assessment of proteinuria. , 1983, British medical journal.